Trial NCT03854500

View at ClinicalTrials.gov 
Org. Study IDs: 2018-003090-95

Last trial update was posted on 2023-09-15

MeSH Interventions

Tenecteplase Tissue Plasminogen Activator

MeSH Conditions

Cerebrovascular Disorders Ischemic Stroke Stroke

Other Conditions

Stroke, Acute

Stopping Reasons

Per protocol safety analysis 200 patients showed a significant difference in bleeding rates between the two drug groups.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID